Product Information
IBUPROFEN 400 MG TABLET is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.0397 per EA under NDC 65162046410. Its NADAC has been published 394 times since Dec 12, 2018.
Strength
400 mg/1
Manufacturer
Amneal Pharmaceuticals LLCNDC
65162046410
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA078558On Market Since
11/23/2009
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 400 MG TABLET has been published 394 times since Dec 12, 2018, and over the history we have for it it has risen 11.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0397 per EA |
|---|---|
| All-time high | $0.0577 (Sep 15, 2021) |
| All-time low | $0.0338 (Nov 20, 2024) |
| 52-week high | $0.0444 |
| 52-week low | $0.0387 |
| Median price | $0.0475 |
| Average price | $0.0473 |
| Largest weekly change | -25.2% (Nov 20, 2024) |
| Weeks tracked | 394 |
| Tracking since | Dec 12, 2018 |
Generic Alternatives
The matcher finds 14 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IBUPROFEN 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 400 MG TABLET, manufactured by Amneal Pharmaceuticals LLC, is $0.0397 per EA (NDC 65162046410), effective Jun 24, 2026.
How has the price of IBUPROFEN 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 400 MG TABLET has risen 11.1%. It has been tracked across 394 weekly CMS publications since Dec 12, 2018.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 400 MG TABLET?
Since Dec 12, 2018, the NADAC for IBUPROFEN 400 MG TABLET has ranged from a low of $0.0338 (Nov 20, 2024) to a high of $0.0577 (Sep 15, 2021), with a median of $0.0475 per EA.
Are there cheaper alternatives to IBUPROFEN 400 MG TABLET?
14 NADAC-published products share the same active ingredient, strength, and dosage form as IBUPROFEN 400 MG TABLET, but none are currently priced below it.
Who manufactures IBUPROFEN 400 MG TABLET?
IBUPROFEN 400 MG TABLET (NDC 65162046410) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification